I believe in Barclays' overweight recommendation!

Since the recent financial results were announced. $Sangamo Therapeutics (SGMO.US)$ It's been dropping a lot, but the analyst ratings are still good, right?

$Pixelworks (PXLW.US)$ Sold the and added sangamo therapeutics!